Impact of Cheap Obesity Drug Copies on Eli Lilly Sales in India
India is witnessing a significant rise in cheap copies of the drug 'semaglutide', negatively affecting sales for Eli Lilly. This situation raises questions about the company's future as patent expirations approach.